Monthly Archives: March 2012

VX-222 SB 203580 Pomalidomide have not been performed directly examining the safety

Posted on March 1, 2012 by admin

In one study of 593 patients, set up a baseline Eastern Cooperative Oncology Group performance status was observed in 30% of patients 70 yr of age versus 9% of people 70 yr VX-222. The presence of comorbidities and decreased performance … Continue reading →

Posted in inhibitors | Leave a comment